A webinar from Thermo Fisher Scientific aims to help users of ICP technologies prepare for the proposed US Pharmacopeia chapters on trace elemental impurities in pharmaceutical products.
The presentation provides the pharmaceutical industry with information about inductively coupled plasma (ICP) techniques can facilitate compliance with the legislative requirements proposed in US Pharmacopeia (USP) chapters 232 and 233.
The webinar, which is available to view on-demand at the Spectroscopy Now website, is entitled 'Preparing for the Proposed United States Pharmacopeia Chapters on Trace Elemental Impurities in Pharmaceuticals with ICP Techniques'.
Presented by Matthew Cassap, senior ICP applications specialist for Thermo Fisher Scientific, the webinar discusses the limitations of the current USP method governing the analysis of heavy metals in pharmaceutical products.
In addition, the presentation provides a historical background and detailed overview of the proposed new chapters.
The presentation features the Thermo Scientific Icap 6000 series ICP spectrometer, demonstrating the efficiency of ICP techniques for the reproducible analysis of trace elemental impurities in pharmaceuticals in compliance with the upcoming regulatory requirements.
In addition, Thermo Scientific Iteva security software plays a key role in legislative compliance efforts as it allows for optimisation of instrument parameters and elimination of interferences, delivering accuracy and reliability of results.
The webinar will also discuss other elemental analysis techniques and how these can be utilised for the analysis of trace elemental impurities in pharmaceuticals.
